Corebridge Financial’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,933
| Closed | -$78.7K | – | 455 |
|
|
2025
Q1 | $78.7K | Buy |
13,933
+3,163
| +29% | +$17.9K | ﹤0.01% | 2561 |
|
|
2024
Q4 | $93.5K | Buy |
10,770
+29
| +0.3% | +$252 | ﹤0.01% | 2582 |
|
|
2024
Q3 | $74.4K | Buy |
10,741
+81
| +0.8% | +$561 | ﹤0.01% | 2743 |
|
|
2024
Q2 | $66.2K | Buy |
+10,660
| New | +$66.2K | ﹤0.01% | 2801 |
|